Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Disease-Modifying Therapies
Share |

The Use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence
A Consensus Paper by the Multiple Sclerosis Coalition, Updated on March 2017

The member organizations of the Multiple Sclerosis Coalition* have collaborated to summarize the current evidence about disease modification in multiple sclerosis (MS) and to provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people. Endorsed by each of the seven MS Coalition organizations, this document serves as an evidence-based resource and reference tool for the clinical management of MS that may also be utilized in advocacy efforts to improve access to approved disease-modifying therapies for people living with MS.

*The Multiple Sclerosis Coalition (see p. 32), which was founded in 2005 to increase opportunities for cooperation and provide greater opportunity to leverage the effective use of resources for the benefit of the MS community, includes Accelerated Cure Project for Multiple Sclerosis, Can Do Multiple Sclerosis, Consortium of Multiple Sclerosis Centers, International Organization of Multiple Sclerosis Nurses, Multiple Sclerosis Association of America, Multiple Sclerosis Foundation, National Multiple Sclerosis Society and the United Spinal Association.

DMT Consensus

More InfoHide Info ]
Purpose: The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States.
Item Name Posted By Date Posted
DMT Consensus PDF (2.01 MB) Administration 6/15/2017
DMT_Consensus_MS_Coalition092016.pdf PDF (1.13 MB) Administration 9/8/2016
DMT_ConsensusMSC_color.pdf PDF (582.55 KB) Administration 9/8/2016
DMT_ConsensusMSC_grey.pdf PDF (569.88 KB) Administration 9/8/2016
DMT_ConsensusMSC_summary_v2.pdf PDF (786.98 KB) Administration 9/8/2016
3 University Plaza Drive, Suite 116
Hackensack, NJ 07601
Tel: 201-487-1050 | Fax: 862-772-7275
Privacy Policy | Disclaimer